Showing results (361-370 of 1,027) with videos related to
Sort By:
Pageof 103
Neurology|November 1, 1989
Rationale for continuous dopaminomimetic therapy of Parkinson's diseaseT N Chase, F Baronti, G Fabbrini, et al.European Journal of Neurology|January 26, 2008
Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasmG Fabbrini, P Pantano, P Totaro, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1987
Controlled release levodopa treatment of motor fluctuations in Parkinson's diseaseJ L Juncos, G Fabbrini, M M Mouradian, et al.Cerebral Cortex (New York, N.Y. : 1991)|January 7, 2010
Dopamine influences primary motor cortex plasticity and dorsal premotor-to-motor connectivity in Parkinson's diseaseA Suppa, E Iezzi, A Conte, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 23, 2009
Somatosensory temporal discrimination in patients with primary focal dystoniaA Scontrini, A Conte, G Defazio, et al.European Journal of Neurology|January 4, 2012
Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivityA Conte, A Giannantoni, S Proietti, et al.Annals of Neurology|May 1, 1989
Pathogenesis of dyskinesias in Parkinson's diseaseM M Mouradian, I J Heuser, F Baronti, et al.Clinical Neuropharmacology|October 1, 1989
Effects of terguride in patients with Huntington's diseaseF Stocchi, A Carta, A Berardelli, et al.Headache|June 1, 1991
Migraine and epilepsy with infantile onset and electroencephalographic findings of occipital spike-wave complexesF De Romanis, M G Buzzi, R Cerbo, et al.Neuropeptides|November 1, 1986
Spinal fluid CRF reduction in Alzheimer's diseaseM M Mouradian, J M Farah, E Mohr, et al.Pageof 103